[Mutagenic activity of antineoplastic agents under conditions of normal and artificial modification]

Genetika
|November 1, 1990
PubMed

Insights

The mutagenic effects of various antitumor agents were studied in Crepis capillaris seeds. Metabolic conditions and cell cycle changes influenced how these chemicals induced mutations.

Area of Science:

  • Genetics
  • Molecular Biology
  • Toxicology

Context:

  • Investigates the mutagenic potential of specific antitumour agents.
  • Focuses on the G phase of the cell cycle in Crepis capillaris.
  • Examines the impact of metabolic conditions on mutagenicity.

Purpose:

  • To elucidate the mutagenic effects of vincristine, vinblastine, thiophosphamide, sarcolysine, and ethyleneimine.
  • To understand how cellular processes modify the mutagenic action of these compounds.
  • To assess the role of DNA synthesis inhibition in the mutagenic process.

Summary:

  • The study evaluated the mutagenic effects of several antitumour drugs and ethyleneimine in germinating Crepis capillaris seeds during the G phase.
  • Findings indicate that metabolic state, cell cycle duration, drug concentration, and DNA synthesis inhibition significantly alter the mutagenic outcomes.
  • These factors modulate the mutagenic process induced by the tested antitumour agents.

Impact:

  • Provides insights into the genotoxicity of common antitumour therapies.
  • Highlights the importance of cellular context in determining drug-induced mutations.
  • Informs risk assessment for exposure to cytotoxic agents.

Related Concept Videos

Mutations01:39

Mutations

Overview
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).